John A. Ward

Array ( [id] => 4173770 [patent_doc_number] => 06036951 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders' [patent_app_type] => 1 [patent_app_number] => 8/913865 [patent_app_country] => US [patent_app_date] => 1997-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 4306 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/036/06036951.pdf [firstpage_image] =>[orig_patent_app_number] => 913865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7634517 [patent_doc_number] => 06657103 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-02 [patent_title] => 'Human antibodies derived from immunized xenomice' [patent_app_type] => B1 [patent_app_number] => 08/923138 [patent_app_country] => US [patent_app_date] => 1997-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 27 [patent_no_of_words] => 10600 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/657/06657103.pdf [firstpage_image] =>[orig_patent_app_number] => 08923138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 793037 [patent_doc_number] => 06982082 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-03 [patent_title] => 'Gene therapy by cell specific targeting' [patent_app_type] => utility [patent_app_number] => 08/922240 [patent_app_country] => US [patent_app_date] => 1997-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25435 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/982/06982082.pdf [firstpage_image] =>[orig_patent_app_number] => 08922240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4059435 [patent_doc_number] => 06007807 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Induction of tumour immunity by injection of hybrid cells' [patent_app_type] => 1 [patent_app_number] => 8/917216 [patent_app_country] => US [patent_app_date] => 1997-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1903 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/007/06007807.pdf [firstpage_image] =>[orig_patent_app_number] => 917216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4265828 [patent_doc_number] => 06306651 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Specific tolerance in transplantation' [patent_app_type] => 1 [patent_app_number] => 8/910287 [patent_app_country] => US [patent_app_date] => 1997-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 11307 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306651.pdf [firstpage_image] =>[orig_patent_app_number] => 910287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560250 [patent_doc_number] => 06361770 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'Method of enhancing expression of MHC class I molecules bearing endogenous peptides' [patent_app_type] => B1 [patent_app_number] => 08/817731 [patent_app_country] => US [patent_app_date] => 1997-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 13687 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/361/06361770.pdf [firstpage_image] =>[orig_patent_app_number] => 08817731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 972079 [patent_doc_number] => 06936464 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-30 [patent_title] => 'Immune responses to fusion proteins' [patent_app_type] => utility [patent_app_number] => 08/896535 [patent_app_country] => US [patent_app_date] => 1997-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 22 [patent_no_of_words] => 14981 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/936/06936464.pdf [firstpage_image] =>[orig_patent_app_number] => 08896535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383045 [patent_doc_number] => 06262032 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Method of destroying hyperproliferative cells by combined p53 and taxoid treatment' [patent_app_type] => 1 [patent_app_number] => 8/875222 [patent_app_country] => US [patent_app_date] => 1997-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 7243 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262032.pdf [firstpage_image] =>[orig_patent_app_number] => 875222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1202816 [patent_doc_number] => 06720309 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-13 [patent_title] => 'Method of inducing vasodilation and treating pulmonary hypertension using adenoviral-mediated transfer of the nitric oxide synthase gene' [patent_app_type] => B1 [patent_app_number] => 08/896053 [patent_app_country] => US [patent_app_date] => 1997-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 9067 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/720/06720309.pdf [firstpage_image] =>[orig_patent_app_number] => 08896053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4232544 [patent_doc_number] => 06090378 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Composition comprising interleukin-2 and thymidine kinase for the treatment of tumors' [patent_app_type] => 1 [patent_app_number] => 8/895588 [patent_app_country] => US [patent_app_date] => 1997-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2524 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090378.pdf [firstpage_image] =>[orig_patent_app_number] => 895588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4396485 [patent_doc_number] => 06297219 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'Site-specific instillation of cells or site-specific transformation of cells and kits therefor' [patent_app_type] => 1 [patent_app_number] => 8/889399 [patent_app_country] => US [patent_app_date] => 1997-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9691 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/297/06297219.pdf [firstpage_image] =>[orig_patent_app_number] => 889399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575098 [patent_doc_number] => 06468982 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Genetic immunization' [patent_app_type] => B1 [patent_app_number] => 08/880576 [patent_app_country] => US [patent_app_date] => 1997-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 29826 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468982.pdf [firstpage_image] =>[orig_patent_app_number] => 08880576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4324167 [patent_doc_number] => 06312684 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Method of inducing resistance to tumor growth' [patent_app_type] => 1 [patent_app_number] => 8/864641 [patent_app_country] => US [patent_app_date] => 1997-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16044 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312684.pdf [firstpage_image] =>[orig_patent_app_number] => 864641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4171656 [patent_doc_number] => 06083741 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Internalisation of DNA, using conjugates of poly-l-lysine and an integrin receptor ligand' [patent_app_type] => 1 [patent_app_number] => 8/836786 [patent_app_country] => US [patent_app_date] => 1997-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 3392 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083741.pdf [firstpage_image] =>[orig_patent_app_number] => 836786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420740 [patent_doc_number] => 06503503 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-07 [patent_title] => 'Allogeneic cellular vaccine' [patent_app_type] => B1 [patent_app_number] => 08/855280 [patent_app_country] => US [patent_app_date] => 1997-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 8644 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/503/06503503.pdf [firstpage_image] =>[orig_patent_app_number] => 08855280 [rel_patent_id] =>[rel_patent_doc_number] =>)